Healthcare Triangle is trading at $1.24 (8.3% up) in after-hours trading, partially rebounding as investors reassess the company's $23.5 million acquisition of CosmoAesthetics.
- The deal involves a 51% majority stake in MedTech firm CosmoAesthetics, funded through a combination of cash, equity, and performance-based consideration.
- The stock's recovery follows a sharp regular-session drop, with the broader market's strength contributing to a more positive outlook on the strategic move.